Next Genomics is a research-driven company that focuses on providing advanced solutions in the fields of genomics, proteomics, metabolomics, and bioinformatics. Their mission is to bridge the gap between academia and industry, offering customized services that enhance the health of people, animals, and plants while also contributing to environmental protection. The company operates both in Italy and internationally, delivering high-quality services to analysis laboratories, research institutes, and healthcare facilities. Their approach emphasizes excellence, with a commitment to high-quality standards and reliability in results, supported by a multidisciplinary team of qualified professionals.

The company is involved in various innovative projects that address environmental and health challenges. For instance, they are engaged in the SLUDGE 4.0 project, which focuses on transforming biological sludge into biofertilizers, and the INTEGRATED PHYTOSANITARY management of pine forests, which aims to monitor and control harmful pests. Additionally, Next Genomics conducts environmental monitoring of glyphosate in relation to bee populations and surface waters. Their research also extends to personalized medicine, with projects like SMART, which develops strategies for diagnosing and treating kidney diseases in children, and MIRDEP, which investigates microRNAs associated with depressive syndrome. Through these initiatives, Next Genomics demonstrates its commitment to innovative research and development across multiple sectors.

Italy

NEXT Genomics è il risultato di un progetto innovativo e di un nuovo modo di fare ricerca. Un punto di contatto tra il mondo accademico e le imprese, un network ad elevata specializzazione mediante il quale fornire soluzioni personalizzate per migliorare la salute di persone, animali e piante; per proteggere l’ambiente e implementare tecnologie, materiali e processi in ambito industriale.

Next Genomics

Company Details